D M Oh - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

D M Oh

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Pediatric Research|May 1, 1991

Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertensionC E Johnson, R H Beekman, D A Kostyshak, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001

Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporterX Y Chu, G P Sánchez-Castaño, K Higaki, et al.

Journal of Pharmaceutical Sciences|March 3, 1999

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugsH K Han, J K Rhie, D M Oh, et al.

The British Journal of Ophthalmology|November 19, 2004

Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosaK T Oh, D M Oh, R G Weleber, et al.

Pharmaceutical Research|April 23, 1999

Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonistN Surendran, K M Covitz, H Han, et al.

Pharmaceutical Research|August 26, 1998

5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporterH Han, R L de Vrueh, J K Rhie, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Pediatric Research|May 1, 1991

Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertensionC E Johnson, R H Beekman, D A Kostyshak, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 17, 2001

Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporterX Y Chu, G P Sánchez-Castaño, K Higaki, et al.

Journal of Pharmaceutical Sciences|March 3, 1999

CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugsH K Han, J K Rhie, D M Oh, et al.

The British Journal of Ophthalmology|November 19, 2004

Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosaK T Oh, D M Oh, R G Weleber, et al.

Pharmaceutical Research|April 23, 1999

Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonistN Surendran, K M Covitz, H Han, et al.

Pharmaceutical Research|August 26, 1998

5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporterH Han, R L de Vrueh, J K Rhie, et al.

Pageof 2